Among patients with unstable angina GP IIb-IIIa inhibitors should be considered only in case of evidence of intracoronary thrombus or in case of thrombotic complications (as provisional use). Further, randomized trials are certainly needed in the era of new oral antiplatelet therapies, and with ...
2) GPIIb/IIIa antagonists GpIIb/IIIa受体拮抗剂 3) platelet GPIIb/IIIa receptor antagonist 血小板IIb/IIIa受体拮抗剂 4) GST KGDX fusion protein GPIIb/IIIa拮抗剂 5) platelet glycoprotein IIb/IIIa receptor inhibitor 血小板膜糖蛋白IIb/IIIa受体拮抗剂 ...
Adjunctive blockade of platelet glycoprotein (GP) IIb/IIIa during percutaneous coronary intervention (PCI) or in patients who present with acute coronary syndromes has been effective in reducing platelet-mediated adverse ischemic clinical outcomes (1–6) . Although this class of therapeutic agents has ...
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials SummaryBackground Platelet glycoprotein IIb/IIIa inhibitors have been shown to reduce cardiac complications in patients undergoing percutaneous coronary intervention. The clinical ...
This study in conjunction with other studies of glycoproteinIIb/IIIareceptorinhibitorssuggeststhataclass effect of these agents should not be assumed and suggests that only those agents proven effective for a specific indica- tion should be used in the treatment of patients with acute coronary syndrome...
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy To assess the efficacy of platelet glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes primarily medically managed.We performed a me... M Roffi,Chew ...
intracoronary vs intravenous glycoprotein IIb/IIIa inhibitor useglycoprotein IIb/IIIa (GP IIb/IIIa) inhibitorsEPIC, EPILOG, and EPISTENT trialsmajor adverse cardiac events (MACEcorrected TIMI frame count (CTFC) and myocardial blush grade (MBG
Objective: To review the clinical trials of glycoprotein IIb/IIIa (GPIIb/IIIa) inhibitors for unstable angina or non–ST segment elevation myocardial infarction (MI) and to provide a practice guide for the use of these agents in this setting. Methods: Clinical trials relating to GPIIb/IIIa antag...
英文名称:Glycoprotein IIb/IIIa 品牌厂商性质产地货期 MedChemExpress (MCE)生产商美国现货 询底价 AI问答 配套的仪器设备?可以搭配的相关耗材试剂? 产品介绍 更多详情参考:https://www.medchemexpress.cn/proteins/glycoprotein-iib-iiia.html Glycoprotein IIb/IIIa | 重组蛋白 | MCE信息由MedChemExpress (MCE)为您...
Early glycoprotein IIb/IIIa inhibitors in patients with non鈥揝T-segment elevation myocardial infarction * * Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily repres...